CAF01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAF01, covering 2013-01-21 to 2013-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers [Phase 1]